Abstract
Malignancy risk in transplant recipients is higher than in the general population. We present synchronous urological malignancies – papillary carcinoma of the native kidney and ductal adenocarcinoma of the prostate in a renal transplant recipient. Clear-cell carcinoma and papillary carcinoma are common renal tumors in transplant recipients. Contrast-enhanced computed tomography helped in the diagnosis of tumor in the native kidney. To the best of our knowledge, ductal adenocarcinoma of the prostate in renal transplant recipients has not been reported. Ductal adenocarcinoma is an aggressive subtype of prostatic carcinomas with lesser prostate-specific acid elevation which has a bearing on diagnosis and management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
